Disc Medicine, Inc.
IRON
$58.97
-$0.79-1.32%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 37.47M | 33.05M | 30.45M | 26.81M | 24.67M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 138.20M | 129.72M | 124.88M | 110.99M | 97.46M |
| Operating Income | -138.20M | -129.72M | -124.88M | -110.99M | -97.46M |
| Income Before Tax | -116.02M | -109.00M | -103.27M | -90.89M | -80.52M |
| Income Tax Expenses | 469.00K | 355.00K | 211.00K | 117.00K | 81.00K |
| Earnings from Continuing Operations | -116.49 | -109.36 | -103.48 | -91.00 | -80.60 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -116.49M | -109.36M | -103.48M | -91.00M | -80.60M |
| EBIT | -138.20M | -129.72M | -124.88M | -110.99M | -97.46M |
| EBITDA | -138.05M | -129.56M | -124.71M | -110.80M | -97.36M |
| EPS Basic | -3.92 | -3.98 | -3.97 | -3.66 | -3.37 |
| Normalized Basic EPS | -2.44 | -2.48 | -2.51 | -2.32 | -2.10 |
| EPS Diluted | -3.92 | -3.98 | -3.97 | -3.66 | -3.37 |
| Normalized Diluted EPS | -2.44 | -2.48 | -2.51 | -2.32 | -2.10 |
| Average Basic Shares Outstanding | 118.90M | 110.39M | 104.84M | 99.22M | 95.06M |
| Average Diluted Shares Outstanding | 118.90M | 110.39M | 104.84M | 99.22M | 95.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |